{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:26:28Z","timestamp":1786112788959,"version":"build-2736575974"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,8]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Observational studies suggest a relationship between hemoglobin (Hb) levels and metabolic dysfunction-associated steatotic liver disease (MASLD), but its specific nature remains unclear. This study aimed to clarify the association through a National Health and Nutrition Examination Survey (NHANES) cross-sectional analysis and a 2-sample Mendelian randomization (MR) approach. We utilized NHANES data from 49,693 participants (2009\u20132018). Weighted multivariate logistic regression examined the Hb-MASLD association, with smoothed curve fitting and threshold effect analysis exploring nonlinear relationships. MR analyses assessed the observed causal relationship. Among 6165 NHANES participants, higher Hb levels were positively associated with MASLD risk (odds ratio\u2005=\u20051.15, 95% confidence interval\u2005=\u20051.08\u20131.23). Notably, when Hb concentrations exceeded 12.9\u2009g\/dL, MASLD risk significantly increased (odds ratio\u2005=\u20051.25, 95% confidence interval\u2005=\u20051.18\u20131.32). Two-sample MR analysis supported a causal relationship between elevated Hb levels and increased MASLD risk. Sensitivity analyses confirmed robustness (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&gt;\u2005.05). This study demonstrates that higher Hb levels are associated with an increased risk of MASLD, revealing potential nonlinear trends. MR analysis further confirmed this causal relationship, suggesting Hb levels could be a target for early intervention in preventing MASLD. These findings underscore the need for additional research to explore Hb\u2019s role in MASLD development and to inform clinical guidelines.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048714","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:04:10Z","timestamp":1778745850000},"page":"e48714","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Identifying the association between hemoglobin levels and metabolic dysfunction-associated steatotic liver disease: An observational study and Mendelian randomization analysis"],"prefix":"10.1097","volume":"105","author":[{"given":"Yang","family":"Qu","sequence":"first","affiliation":[{"name":"Department of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxing","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Radiology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6354-1060","authenticated-orcid":false,"given":"Feifei","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260805","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease.","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"R2-20260805","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss.","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"R3-20260805","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement.","volume":"73","author":"Slam","year":"2020","journal-title":"J Hepatol"},{"key":"R4-20260805","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R5-20260805","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"key":"R6-20260805","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R7-20260805","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R8-20260805","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease \u2013 a global public health perspective.","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"R9-20260805","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s40618-022-01848-w","article-title":"Sex-specific metabolic risk factors and their trajectories towards the non-alcoholic fatty liver disease incidence.","volume":"45","author":"Tong","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"R10-20260805","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.1039\/D2FO04082D","article-title":"Association of iron status with non-alcoholic fatty liver disease and liver fibrosis in US adults: a cross-sectionalstudy from NHANES 2017-2018.","volume":"14","author":"Tan","year":"2023","journal-title":"Food Funct"},{"key":"R11-20260805","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/apt.12255","article-title":"Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease.","volume":"37","author":"Beaton","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R12-20260805","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/ajg.2017.5","article-title":"Prevalence of nonalcoholic steatohepatitis-associated cirrhosis in the United States: an analysis of National Health and Nutrition Examination Survey data.","volume":"112","author":"Kabbany","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"R13-20260805","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.csbj.2022.05.015","article-title":"Statistical methods for Mendelian randomization in genome-wide association studies: a review.","volume":"20","author":"Boehm","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"R14-20260805","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/ije\/dyv108","article-title":"Mendelian randomization: where are we now and where are we going?","volume":"44","author":"Burgess","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R15-20260805","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"R16-20260805","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12471-014-0534-z","article-title":"Using genetic variation for establishing causality of cardiovascular risk factors: overcoming confounding and reverse causality.","volume":"22","author":"Smit","year":"2014","journal-title":"Neth Heart J"},{"key":"R17-20260805","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1742-1241.2009.02056.x","article-title":"Observational studies: a review of study designs, challenges and strategies to reduce confounding.","volume":"63","author":"Lu","year":"2009","journal-title":"Int J Clin Pract"},{"key":"R18-20260805","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/apt.13012","article-title":"Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey.","volume":"41","author":"Ruhl","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R19-20260805","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1016\/j.cgh.2021.12.015","article-title":"Prevalence of high and moderate risk nonalcoholic fatty liver disease among adults in the United States, 1999-2016.","volume":"20","author":"Golabi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R20-20260805","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","article-title":"Epidemiology of chronic liver diseases in the USA in the past three decades.","volume":"69","author":"Younossi","year":"2020","journal-title":"Gut"},{"key":"R21-20260805","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/joim.13069","article-title":"Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016.","volume":"288","author":"Zou","year":"2020","journal-title":"J Intern Med"},{"key":"R22-20260805","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology.","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"R23-20260805","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/ije\/dyq151","article-title":"Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants.","volume":"40","author":"Pierce","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R24-20260805","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"R25-20260805","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R26-20260805","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R27-20260805","doi-asserted-by":"crossref","first-page":"537","DOI":"10.5009\/gnl19236","article-title":"Characteristic features of nonalcoholic fatty liver disease in Japan with a focus on the roles of age, sex and body mass index.","volume":"14","author":"Tobari","year":"2020","journal-title":"Gut Liver"},{"key":"R28-20260805","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cgh.2020.04.067","article-title":"Women have a lower risk of nonalcoholic fatty liver disease but a higher risk of progression vs men: a systematic review and meta-analysis.","volume":"19","author":"Balakrishnan","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R29-20260805","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1002\/fsn3.2261","article-title":"Association of serum selenium with anemia-related indicators and risk of anemia.","volume":"9","author":"Zhou","year":"2021","journal-title":"Food Sci Nutr"},{"key":"R30-20260805","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/JBM.S349070","article-title":"Relationship between initial parenteral iron therapy dosing and treatment effectiveness: a real-world retrospective analysis.","volume":"13","author":"LaVallee","year":"2022","journal-title":"J Blood Med"},{"key":"R31-20260805","doi-asserted-by":"crossref","first-page":"54677","DOI":"10.1021\/acsami.1c14674","article-title":"Fluorescent egg white-based carbon dots as a high-sensitivity iron chelator for the therapy of nonalcoholic fatty liver disease by iron overload in zebrafish.","volume":"13","author":"Yu","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"key":"R32-20260805","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1055\/s-0039-1693114","article-title":"Hyperferritinemia in nonalcoholic fatty liver disease: iron accumulation or inflammation?","volume":"39","author":"Moris","year":"2019","journal-title":"Semin Liver Dis"},{"key":"R33-20260805","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ebiom.2018.11.020","article-title":"Liver iron load influences hepatic fat fraction in end-stage renal disease patients on dialysis: a proof of concept study.","volume":"39","author":"Rostoker","year":"2019","journal-title":"EBioMedicine"},{"key":"R34-20260805","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12876-018-0804-0","article-title":"Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease.","volume":"18","author":"Marmur","year":"2018","journal-title":"BMC Gastroenterol"},{"key":"R35-20260805","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1177\/15353702231191197","article-title":"Selective autophagy associated with iron overload aggravates non-alcoholic steatohepatitis via ferroptosis.","volume":"248","author":"Honma","year":"2023","journal-title":"Exp Biol Med (Maywood)"},{"key":"R36-20260805","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/ijms17040548","article-title":"Role of serum uric acid and ferritin in the development and progression of NAFLD.","volume":"17","author":"Lombardi","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R37-20260805","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12870-023-04688-9","article-title":"Biochemical and proteomic response of the freshwater green alga Pseudochlorella pringsheimii to iron and salinity stressors.","volume":"24","author":"Ismaiel","year":"2024","journal-title":"BMC Plant Biol"},{"key":"R38-20260805","doi-asserted-by":"crossref","first-page":"e2200061","DOI":"10.1002\/pmic.202200061","article-title":"Effects of 4-Br-A23187 on Bacillus subtilis cells and unilamellar vesicles reveal it to be a potent copper ionophore.","volume":"22","author":"Senges","year":"2022","journal-title":"Proteomics"},{"key":"R39-20260805","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1365-2036.2005.02517.x","article-title":"Gender and liver fibrosis in chronic hepatitis: the role of iron status.","volume":"21","author":"Rigamonti","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R40-20260805","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/JLB.3A0318-108R","article-title":"Iron alters macrophage polarization status and leads to steatohepatitis and fibrogenesis.","volume":"105","author":"Handa","year":"2019","journal-title":"J Leukoc Biol"},{"key":"R41-20260805","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s40168-021-01052-7","article-title":"Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome.","volume":"9","author":"Mayneris-Perxachs","year":"2021","journal-title":"Microbiome"},{"key":"R42-20260805","first-page":"801","article-title":"Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions.","volume":"18","author":"Rajaram","year":"1997","journal-title":"Endocr Rev"},{"key":"R43-20260805","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/nu9060624","article-title":"Zinc in infection and inflammation.","volume":"9","author":"Gammoh","year":"2017","journal-title":"Nutrients"},{"key":"R44-20260805","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/MEG.0000000000001587","article-title":"Correlation of serum zinc levels with pathological and laboratory findings in patients with nonalcoholic fatty liver disease.","volume":"32","author":"Ito","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R45-20260805","doi-asserted-by":"crossref","first-page":"1365448","DOI":"10.3389\/fncel.2024.1365448","article-title":"Peripheral inflammation as a potential mechanism and preventive strategy for perioperative neurocognitive disorder under general anesthesia and surgery.","volume":"18","author":"Li","year":"2024","journal-title":"Front Cell Neurosci"},{"key":"R46-20260805","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/MPG.0000000000001008","article-title":"Contrast-based real-time assessment of microcirculatory changes in a fatty liver after ischemia reperfusion injury.","volume":"62","author":"Kolachala","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048714","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:03:13Z","timestamp":1785945793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":46,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048714","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"2025-10-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}